ABERA BIOSCIENCE AB Cash Flow-to-Debt Ratio
ABERA BIOSCIENCE AB cash flow-to-debt ratio. ABERA BIOSCIENCE AB (8WK) has a Cash Flow-to-Debt Ratio of -0.98x as of March 2026, meaning its operating cash flow of €-7.44 Million could theoretically repay -1% of its total liabilities (€7.57 Million) in one year. Check ABERA BIOSCIENCE AB (8WK) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ABERA BIOSCIENCE AB (2022–2025)
Cash flow-to-debt ratio of ABERA BIOSCIENCE AB from 2022 to 2025. Historical debt coverage capacity for ABERA BIOSCIENCE AB across 4 annual periods. Check ABERA BIOSCIENCE AB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
ABERA BIOSCIENCE AB Cash Flow-to-Debt Ratio by Year (2022–2025)
ABERA BIOSCIENCE AB cash flow-to-debt ratio by year from 2022 to 2025. Year-by-year debt coverage analysis for ABERA BIOSCIENCE AB. For the full cash flow conversion analysis, see ABERA BIOSCIENCE AB cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.35x | €-3.26 Million | €9.28 Million | ▼ -777.2% |
| 2024 | -0.04x | €-198.00K | €4.95 Million | ▲ +99.2% |
| 2023 | -4.80x | €-17.71 Million | €3.69 Million | ▲ +31.9% |
| 2022 | -7.05x | €-19.69 Million | €2.80 Million | — |